XML 94 R86.htm IDEA: XBRL DOCUMENT v3.25.1
Net Loss Per Share - Schedule of Basic and Diluted Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2025
Mar. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Net loss $ (6,139) $ (4,078) $ (6,938) $ (6,724) $ (10,217) $ (13,662)
Basic loss per share $ (0.14)   $ (0.16)   $ (0.23) $ (0.31)
Diluted loss per share $ (0.14)   $ (0.16)   $ (0.23) $ (0.31)
Weighted average shares outstanding - basic (in shares) 45,002,197   44,247,858   44,956,697 44,026,750
Assumed exercise of dilutive options (in shares) 0   0   0 0
Weighted average shares outstanding - diluted (in shares) 45,002,197   44,247,858   44,956,697 44,026,750
Antidilutive (in shares) 7,840,909   3,940,925   7,840,909 3,940,925
Employee Stock Option [Member]            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Antidilutive (in shares) 4,475,385   3,377,824   4,475,385 3,377,824
Restricted Stock Units (RSUs) [Member]            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Antidilutive (in shares) 297,342   292,831   297,342 292,831
Warrant [Member]            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Antidilutive (in shares) 3,068,182   0   3,068,182 0
Obligation to Issue Common Stock [Member]            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Antidilutive (in shares) 0   270,270   0 270,270